Log in or Sign up for Free to view tailored content for your specialty!
Gastrointestinal Conditions News
Digestive enzyme cartridge cleared for use in children
Alcresta Therapeutics, Inc. has received 510(k) clearance from the FDA for the use of its digestive enzyme cartridge Relizorb in pediatric patients as young as 5 years old with fat malabsorption, according to a press release.
IBD risk lower in children from rural areas
People who live in rural areas, especially children who grow up there, have a lower risk for developing inflammatory bowel disease, according to the results of a Canadian population-based cohort study.
Log in or Sign up for Free to view tailored content for your specialty!
Yemen’s cholera outbreak is largest in recorded history
The cholera outbreak in war-torn Yemen is still infecting 5,000 patients per day and has grown to become the largest single-year outbreak of the diarrheal disease in recorded history, officials said.
California health officials battle state’s largest hepatitis A outbreak in 2 decades
The California Department of Public Health is working with local health officials in San Diego and Santa Cruz counties to contain the state’s largest hepatitis A outbreak in 2 decades.
FDA awards $30 million to improve food safety, reduce foodborne illness
The FDA has awarded $30.9 million to 43 states to support multiyear plans for produce safety systems, education, outreach and technical assistance to prevent foodborne illnesses, according to a statement made by FDA Commissioner Scott Gottlieb, MD.
Pediatric IBD Issues are Universal, with Transition Being the Next Step
In reading our cover story this month, I found myself agreeing with our experts, knowing that the hurdles they face in pediatric inflammatory bowel disease often carry over to our adult IBD population as well.
Concerns, Controversies in Pediatric IBD Persist in Era of Biologics
The treatment of pediatric inflammatory bowel disease has been revolutionized by the advent of biologic therapies, which have been shown to effectively treat symptoms, induce mucosal healing, and reverse growth impairment in many patients. However, experts continue to debate the positioning of biologics in IBD, and are seeking ways to better understand how to deliver optimal treatment to children affected by the disease.
Billions at risk for diseases without safe drinking water, sanitation
A global report issued by WHO and UNICEF showed that 2.1 billion people live without access to safe, readily available water and 4.5 billion lack proper sanitation, increasing the risk for acquiring and spreading infectious disease.
Drug nonadherence linked to higher health care costs in young IBD patients
New researched showed an association between nonadherence to medications for inflammatory bowel disease and increased health care costs in young patients, especially in those whose nonadherence increased over time, according to new research.
Epidemic strains of C. difficile detected within playground sandboxes
Sandboxes in playgrounds that are unprotected from dogs and other wild animals may harbor Clostridium difficile and expose children to the bacteria at epidemic levels, according to a study published in Zoonoses and Public Health.
-
Headline News
CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots
November 18, 20241 min read -
Headline News
Obesity drugs could help lower alcohol intake
November 18, 20243 min read -
Headline News
Pediatric asthma ‘potential source of cognitive difficulty’
November 18, 20242 min read
-
Headline News
CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots
November 18, 20241 min read -
Headline News
Obesity drugs could help lower alcohol intake
November 18, 20243 min read -
Headline News
Pediatric asthma ‘potential source of cognitive difficulty’
November 18, 20242 min read